Enanta Pharmaceuticals
ENTA
ENTA
179 hedge funds and large institutions have $1.4B invested in Enanta Pharmaceuticals in 2021 Q4 according to their latest regulatory filings, with 44 funds opening new positions, 65 increasing their positions, 49 reducing their positions, and 11 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding in top 10
Funds holding in top 10: →
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more capital invested
Capital invested by funds: $ → $
22% more funds holding
Funds holding: 147 → 179 (+32)
3.51% less ownership
Funds ownership: 95.94% → 92.44% (-3.5%)
88% less call options, than puts
Call options by funds: $2.86M | Put options by funds: $23.5M
Holders
179
Holding in Top 10
4
Calls
$2.86M
Puts
$23.5M
Top Buyers
| 1 | +$13.7M | |
| 2 | +$12.4M | |
| 3 | +$12.1M | |
| 4 |
SCM
Soleus Capital Management
Greenwich,
Connecticut
|
+$10.2M |
| 5 |
FFM
Fairmount Funds Management
West Conshohocken,
Pennsylvania
|
+$5.27M |
Top Sellers
| 1 | -$58.3M | |
| 2 | -$31.5M | |
| 3 | -$27.9M | |
| 4 |
Vanguard Group
Malvern,
Pennsylvania
|
-$13M |
| 5 |
BlackRock
New York
|
-$9.25M |